Your browser doesn't support javascript.
loading
Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
Tait, Sarah D; Ren, Yi; Horton, Cushanta C; Oshima, Sachiko M; Thomas, Samantha M; Wright, Sherry; Caesar, Awanya; Plichta, Jennifer K; Hwang, E Shelley; Greenup, Rachel A; Rosenberger, Laura H; DiLalla, Gayle D; Menendez, Carolyn S; Tolnitch, Lisa; Hyslop, Terry; Nelson, Debi; Fayanju, Oluwadamilola M.
Afiliación
  • Tait SD; Duke University School of Medicine, Durham, North Carolina.
  • Ren Y; Duke University School of Medicine, Durham, North Carolina.
  • Horton CC; North Carolina Department of Health and Human Services, Raleigh, North Carolina.
  • Oshima SM; Duke University School of Medicine, Durham, North Carolina.
  • Thomas SM; Duke University School of Medicine, Durham, North Carolina.
  • Wright S; North Carolina Department of Health and Human Services, Raleigh, North Carolina.
  • Caesar A; Lincoln Community Health Center, Durham, North Carolina.
  • Plichta JK; Duke University School of Medicine, Durham, North Carolina.
  • Hwang ES; Duke University School of Medicine, Durham, North Carolina.
  • Greenup RA; Duke University School of Medicine, Durham, North Carolina.
  • Rosenberger LH; Duke University School of Medicine, Durham, North Carolina.
  • DiLalla GD; Duke University School of Medicine, Durham, North Carolina.
  • Menendez CS; Duke University School of Medicine, Durham, North Carolina.
  • Tolnitch L; Duke University School of Medicine, Durham, North Carolina.
  • Hyslop T; Duke University School of Medicine, Durham, North Carolina.
  • Nelson D; North Carolina Department of Health and Human Services, Raleigh, North Carolina.
  • Fayanju OM; Duke University School of Medicine, Durham, North Carolina.
Cancer ; 127(14): 2515-2524, 2021 07 15.
Article en En | MEDLINE | ID: mdl-33826758
ABSTRACT

BACKGROUND:

The North Carolina Breast and Cervical Cancer Control Program (NC BCCCP) provides breast cancer screening services to underserved women to mitigate disparities in access to care. The authors sought to characterize this understudied population.

METHODS:

Women 21 years old or older who underwent their first breast cancer screen through NC BCCCP from 2008 to 2018 were included. Demographic factors associated with the timeline of care and odds of a breast cancer diagnosis were identified with negative binomial and logistic regression, respectively.

RESULTS:

Of the 88,893 women identified, 45.5% were non-Hispanic (NH) White, 30.9% were NH Black, 19.6% were Hispanic, 1.7% were American Indian, and 1.1% were Asian. Breast cancer was diagnosed in 2.5% of the women (n = 2255). Hispanic women were the least likely to be diagnosed with breast cancer (odds ratio vs NH White women, 0.40; 95% confidence interval [CI], 0.34-0.47). Among patients with breast pathology, the median time to diagnosis was 19 days (interquartile range [IQR], 10-33 days), and the time to treatment was 33 days (IQR, 19-54 days). After adjustments, a longer time to diagnosis was significantly associated with age (incidence rate ratio [IRR], 1.01; 95% CI, 1.01-1.02) and being NH Black (vs NH White; IRR, 1.17; 95% CI, 1.06-1.29). A longer time to treatment was significantly associated with age (IRR, 1.01; 95% CI, 1.01-1.01), being NH Black (vs NH White; IRR, 1.20; 95% CI, 1.10-1.31), and being Hispanic (vs NH White; IRR, 1.22; 95% CI, 1.05-1.41).

CONCLUSIONS:

NC BCCCP participants with breast cancer received treatment within approximately 1 month of presentation, and this finding aligns with quality care benchmarks. Nevertheless, racial/ethnic disparities in timeliness of care persist, and this suggests opportunities for improvement. LAY

SUMMARY:

This review of approximately 90,000 participants in a breast cancer screening program for uninsured and underinsured women highlights the importance of safety net programs in providing timely care to underserved patients. The authors found that the North Carolina Breast and Cervical Cancer Control Program met timeliness benchmarks from the Centers for Disease Control and Prevention across all racial/ethnic groups. However, non-Hispanic Black women experienced relative delays in the time to diagnosis, and both non-Hispanic Black women and Hispanic women experienced relative delays in the time to treatment. These findings demonstrate how racial/ethnic disparities in the timeliness of care can persist even within a program intended to reduce barriers to access.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Grupos Raciales Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Límite: Adult / Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Grupos Raciales Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Límite: Adult / Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article
...